YTEN

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Brum Lynne HVP Planning And Communications $8.8k5.9k shares Grant / ExerciseAug 15, 2024 $1.1K731 shares $1.50 --
Haaser Charles BVP Finance And CAO $8.9k5.9k shares Grant / ExerciseAug 15, 2024 $1.1K731 shares $1.50 --
Peoples Oliver PDirector, Officer: President And CEO $19k12.6k shares Grant / ExerciseAug 15, 2024 $2.2K1.5k shares $1.50 --
Snell KristiVP Research And CSO $10k7k shares Grant / ExerciseAug 15, 2024 $1.3K877 shares $1.50 --

Trade YTEN

About Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc. is an agricultural biotechnology firm dedicated to creating advanced solutions that can significantly boost crop productivity across the United States and Canada. Utilizing its proprietary Trait Factory – an innovative gene discovery platform – the company develops enhanced varieties of oilseed Camelina sativa for exclusive seed products. Additionally, it identifies valuable genetic characteristics applicable to both the agricultural and food sectors. Yield10 Bioscience maintains licensing agreements with several key industry players, including GDM Seeds, J. R. Simplot, Forage Genetics International, LLC, and Bayer AG. The company, incorporated in 1992, rebranded from Metabolix, Inc. to Yield10 Bioscience, Inc. in January 2017. Its corporate headquarters are located in Woburn, Massachusetts.

CEO: Oliver P. Peoples
IPO Date: Nov 10, 2006

Market Data

Open: $0.6949
High: $0.6949
Low: $0.3351
Volume: 11.4K
52W High: $17.26
52W Low: $0.2352

Valuation

Market Cap: $345k
Enterprise Value: $2.5M

Financials

Free Cash Flow: $-10M
Revenue: $60k
Net Income: $-14M
Cash: $1.1M
Debt: $3.2M

Events

EarningsAug 12